Veterinary Medicines

Anthelmin Plus XL Tablets for dogs

Authorised
  • Febantel
  • Pyrantel embonate
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Anthelmin Plus XL Tablets for dogs
Anthelmin Plus XL 175 mg - 525 mg - 504 mg Tablet
Anthelmin Plus XL 175 mg - 525 mg - 504 mg Comprimé
Anthelmin Plus XL 175 mg - 525 mg - 504 mg Tablette
Active substance:
  • Febantel
  • Pyrantel embonate
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC55
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • OPA/Al/PVC-Al blister.Cardboard box containing 2 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 4 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 10 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 12 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 24 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 30 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 50 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 60 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 100 tablets.
  • OPA/Al/PVC-Al blister.Cardboard box containing 102 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • Krka-Farma d.o.o.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V392086
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0538/002
Concerned member states:
  • Belgium
  • Bulgaria
  • Finland
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 15/12/2024
Download
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download

Combined File of all Documents

English (PDF)
Published on: 15/12/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download